Syndax Pharmaceuticals Inc (SNDX) stock news · rev $172.4M
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
This SNDX news page leads with what Syndax Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for SNDX yet. We will not pad this page with generic market recap.
Latest reported SNDX revenue for 2025-12-31 was $172.4M. Net income was -$285.4M. Revenue was up 627.8% from 2024-12-31 to 2025-12-31. SNDX currently screens at market cap $774.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SNDX stock page; for the tape open the quote page.
SNDX stock news FAQ
What are SNDX's latest revenue and net income?
Latest cached Syndax Pharmaceuticals Inc (SNDX) revenue for Dec 31, 2025 was $172.4M. Net income was -$285.4M. Statements: https://lician.com/financials/sndx
How did SNDX revenue change from the prior cached period?
Cached Syndax Pharmaceuticals Inc (SNDX) revenue was up 627.8% from $23.7M (Dec 31, 2024) to $172.4M (Dec 31, 2025). Statements: https://lician.com/financials/sndx
What is SNDX's market cap?
Syndax Pharmaceuticals Inc (SNDX) market cap is $774.4M on the latest cached fundamentals snapshot.
What kind of company is SNDX?
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Where is SNDX stock news listed?
Cached stock news for Syndax Pharmaceuticals Inc (SNDX) is listed at https://lician.com/news/sndx. Filings: https://lician.com/sec/sndx
Not investment advice.